Inhibition of vesicular stomatitis virus replication in the course of HIV infection in patients with different stages of immunodeficiency

Viral Immunology

Volumn 23, Issue 6, 2010, Pages 567-576

  Piasecki, Egbert ^a,c   Knysz, Brygida ^b   Zwolińska, Katarzyna ^a   Ga̧siorowski, Jacek ^b   Lorenc, Maria ^a   Zalewska, Małgorzata ^b   Gładysz, Andrzej ^b   Siemieniec, Iwona ^a   Pazgan Simon, Monika ^b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c JAN DLUGOSZ UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; LOPINAVIR PLUS RITONAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBODY TITER; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; VESICULAR STOMATITIS VIRUS; VIREMIA; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERFERONS; MALE; MIDDLE AGED; VESICULAR STOMATITIS INDIANA VIRUS; VIRAL LOAD; VIRUS REPLICATION;

VESICULAR STOMATITIS VIRUS;

EID: 78650091586     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2010.0054     Document Type: Article

References (25)

1. Baca LM, Genis P, Kalvakolanu D, Sen G, Meltzer MS, Zhou A, Silverman R, and Gendelman HE: Regulation of interferon-a-inducible cellular genes in human immunodeficiency virus-infected monocytes. J Leukoc Biol 1994;55: 299-309.
2. Bartz SR, and Vodicka MA: Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods 1997;12:337-342.
3. Błach-Olszewska Z, Jatczak B, Rak A, Lorenc M, Gula-nowski B, Drobna A, and Lamer-Zarawska E: Production of cytokines and stimulation of resistance to viral infection in human leukocytes by Scutellaria baicalensis flavones. J Inter-feron Cytokine Res 2008;28:571-582.
4. Błach-Olszewska Z, Zaczyńska E, Kiełbiński M, and Fry-decka I: Deficiency of innate immunity of leukocytes is associated with the failure of the induction of remission and survival time in patients with acute leukemia. Pol J Environmental Studies 2005;14(Suppl II):36-40.
5. Boritz E, Gerlach J, Johnson JE, and Rose JK: Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. J Virol 1999;73:6937-6945.
6. Chehadeh W, Chabou S, Fontier C, et al.: In HIV-1-infected patients, plasma levels of HIV-1 RNA are inversely correlated with IFN-a responsiveness of whole-blood cultures to Sendai virus. J Clin Virol 2000;16:123-128.
7. Crommentuyn KM, Rosing H, Nan-Offeringa LG, Hilleb-rand MJ, Huitema AD, and Beijnen JH: Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electro-spray ionization tandem mass spectrometry. J Mass Spectrom 2003;38:157-166.
8. Ferran MC, and Lucas-Lenard JM: The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J Virol 1997;71:371-377.
9. Kaletra Tablets. RxList The Internet Drug Index. http://www.rxlist.com/ cgi/generic/kaletratabs-cp.htm.
10. Kedzierska K, and Crowe SM: The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr Med Chem 2002;9:1893-1903.
11. Knysz B, Rybka K, Ga?siorowski J, Piasecki E, Zalewska M, and Gładysz A: Acid labile interferon alpha concentration: prognostic value during immune reconstitution following effective antiretroviral therapy in HIV-1 positive patients. HIV AIDS Rev 2006;5:7-12.
12. Kornbluth RS, Munis JR, Oh PS, Meylan PR, and Richman DD: Characterization of a macrophage-tropic HIV strain that does not alter macrophage cytokine production yet protects macrophages from superinfection by vesicular stomatitis virus. AIDS Res Hum Retroviruses 1990;6:1023-1026.
13. Kuate S, Stahl-Hennig C, Stoiber H, et al.: Immunogenicity and efficacy of immunodeficiency virus-like particles pseu-dotyped with the G protein of vesicular stomatitis virus. Virology 2006;351:133-144.
14. Ohishi M, Shioda T, and Sakuragi J: Retro-transduction by virus pseudotyped with glycoprotein of vesicular stomatitis virus. Virology 2007;362:131-138.
15. Orzechowska B, Antoszków Z, and Błach-Olszewska Z: Individual differentiation of innate antiviral immunity in humans; the role of endogenous interferons and tumor necrosis factor in the immunity of leukocytes. Arch Immunol Ther Exp 2003;51:51-60.
16. Paik SY, Banerjea AC, Harmison GG, Chen CJ, and Schubert M: Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein. J Virol 1995;69:3529-3537.
17. Piasecki E, Knysz B, Ga?siorowski J, and Gładysz A: Decrease of enhanced interferon a levels in sera of HIV-infected and AIDS patients receiving combined antiretroviral therapy. Arch Immunol Ther Exp 1999;47:37-44.
18. Piasecki E, Ledwoń TK, Inglot AD, Knysz B, Simon K, Inglot M, and Gładysz A: Interferon and tumor necrosis factor responses of HIV\+ patients as markers for monitoring of the AIDS progression. Arch Immunol Ther Exp 1994;42:439-445.
19. Rybka K, Orzechowska B, Siemieniec I, Leszek J, Zaczyńska E, Paja?k J, and Błach-Olszewska Z: Age related natural antiviral non-specific immunity of human leukocytes. Med Sci Monitor 2003;9:413-417.
20. Samson M, Libert F, Doranz BJ, et al.: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-725.
21. Sochocka M, Zaczyńska E, Leszek J, Siemieniec I, and Błach-Olszewska Z: Effect of donepezil on innate antiviral immunity of human leukocytes. J Neurol Sci 2008;273:75-80.
22. Swindells S, Baldwin T, Kelly C, et al.: Regulation and characterization of the interferon-alpha present in patients with advanced human immunodeficiency virus type 1 disease. J Interferon Cytokine Res 1996;16:127-137.
23. Whelan SPJ: Vesicular stomatitis virus. In: Encyclopedia of Virology, 3rd ed., Vol. 5. (Mahy BWL, and Van Regenmortel MHV, eds.). Academic Press, Philadelphia, 2008, pp. 291-299.
24. Wójtowicz H, Kloc K, Maliszewska I, Młochowski J, Pie?tka M, and Piasecki E: Azaanalogues of ebselen as antimicrobial and antiviral agents: synthesis and properties. Il Farmaco 2004;59:863-868.
25. Zaczyńska E, Magott-Procelewska M, Rybka K, Siemieniec I, Błach-Olszewska Z, and Klinger M: Innate antiviral immunity is not impaired in chronic renal failure on hemodialysis. Nephron Clin Pract 2005;101:207-210.